Market Outlook
The global Pseudouridine market size was valued at USD 91 million in 2022 and is forecast to a readjusted size of USD 701.9 million by 2029 with a CAGR of 33.9% during review period.
Pseudouridine, an isomer of uridine (U), is used as a tumor marker to guide the diagnosis, monitoring and efficacy assessment of malignancies such as lung, breast and liver cancers. Although normal mRNA present in vivo has uridine as one of the four nucleic acid compounds in the sequence, mRNA developed as a therapeutic agent or vaccine is made using a modified nucleic acid (pseudouridine) instead of uridine (and other derivatives). Pseudouridine was originally present in the body as a component, such as tRNA (transfer RNA), which is a type of RNA.
The Pseudouridine industry can be broken down into several segments, Powder, Liquid, etc. Across the world, the major players cover YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies (Maravai LifeSciences), MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Ulcho Biochemical Ltd (FCAD Group), Wuhan Finetech, etc.
In the global market, the core manufacturers of pseudouridine include YAMASA CORPORATION and Biosynth Carbosynth etc, and the top 2 manufacturers account for about 60% of the market share. The market includes North America, Europe and Asia Pacific, with a share of 50%, 35% and 15%. Powder accounted for 90%. The product is mainly used in vaccines and scientific research, with a share of 80% and 20%.
This report is a detailed and comprehensive analysis for global Pseudouridine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pseudouridine market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Pseudouridine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Pseudouridine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Pseudouridine market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/g), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pseudouridine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pseudouridine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Ulcho Biochemical Ltd(FCAD Group)
Wuhan Finetech
Shanghai Hongene Biotech
Segmentation By Type
Powder
Liquid
Segmentation By Application
Vaccine
Scientific Research
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the pseudouridine market in 2025?
The pseudouridine market in 2025 will likely benefit from the increasing demand for mRNA-based therapeutics. As pseudouridine plays a crucial role in stabilizing mRNA, its usage in vaccine development and gene therapies will continue to rise. Strong scientific validation and investment in biotech and pharma will also drive growth.
What are the weaknesses of the pseudouridine market in 2025?
A major weakness could be the high production costs associated with pseudouridine, as it is a complex molecule to synthesize. Additionally, regulatory hurdles and concerns about the long-term safety of mRNA therapies may slow down market adoption and growth.
What opportunities exist for the pseudouridine market in 2025?
Opportunities lie in expanding its applications beyond vaccines, particularly in gene therapy, personalized medicine, and cancer treatments. As mRNA technology continues to evolve, new partnerships between pharmaceutical companies and biotech firms could lead to innovative applications of pseudouridine.
What threats does the pseudouridine market face in 2025?
The pseudouridine market may face threats from emerging technologies, such as alternative RNA modifications, that offer similar benefits with potentially lower costs. Competition from other synthetic biology solutions and potential public skepticism regarding mRNA-based treatments could also hinder market growth.
Market PESTEL Analysis
What are the political factors influencing the pseudouridine market in 2025?
Government policies supporting biotech innovations, such as grants and tax incentives, will positively influence the pseudouridine market. Additionally, regulatory approval processes for new mRNA-based therapies and vaccines will be key political factors. Any political instability or changes in healthcare regulations could affect market dynamics.
How do economic factors affect the pseudouridine market in 2025?
Economic factors such as the availability of funding for biotech startups and global economic conditions will play a significant role in the market. The high costs of research, production, and development for pseudouridine-based therapies might limit accessibility, especially in developing countries. However, economic recovery and growth in healthcare budgets could boost investment in the field.
What social factors impact the pseudouridine market in 2025?
Public trust in mRNA therapies and vaccines will be a critical social factor. As awareness of pseudouridine's role in mRNA technology increases, consumer acceptance of treatments that involve pseudouridine will grow. Conversely, societal resistance to mRNA technology, especially following controversies, could slow market adoption.
How does technology affect the pseudouridine market in 2025?
Technological advancements in mRNA delivery methods, genetic engineering, and RNA modification processes will directly impact the pseudouridine market. Enhanced synthesis techniques, such as more cost-effective production methods for pseudouridine, will likely increase market growth, improving accessibility and reducing costs.
What environmental factors are relevant to the pseudouridine market in 2025?
Sustainability concerns in pharmaceutical production processes may influence how pseudouridine is manufactured. Biotech companies may face pressure to adopt greener technologies and reduce the environmental impact of production. Regulatory pressures related to environmental standards could also impact market dynamics.
What legal factors affect the pseudouridine market in 2025?
Patent laws and intellectual property rights will have a significant influence on the pseudouridine market. Legal frameworks protecting innovations in mRNA technologies will encourage investment and research. However, potential legal challenges related to patents or disputes over proprietary technologies could impact the market.
Market SIPOC Analysis
Who are the suppliers in the pseudouridine market in 2025?
Suppliers in the pseudouridine market will include manufacturers of raw materials for RNA synthesis, biotech companies specializing in RNA technology, and companies that provide specialized equipment and infrastructure for mRNA research and production. Additionally, suppliers of synthetic biology tools and reagents will also play a role.
What are the inputs in the pseudouridine market in 2025?
The key inputs will include pseudouridine as a raw material, RNA synthesis platforms, advanced biotechnological research, skilled personnel, and significant capital investment. Additionally, regulatory approvals and scientific research data supporting the effectiveness of pseudouridine will serve as critical inputs for market growth.
What processes are involved in the pseudouridine market in 2025?
Processes include the research and development of mRNA-based therapies, synthesis of pseudouridine for mRNA modification, clinical testing of therapies, regulatory approval processes, and the scaling up of production for commercial use. Additionally, the distribution of mRNA-based vaccines or therapies will be part of the overall process.
Who are the customers in the pseudouridine market in 2025?
Customers will primarily include pharmaceutical companies developing mRNA-based therapies, biotech companies involved in gene therapy and vaccine production, and academic institutions or research organizations focused on advancing RNA technologies. Healthcare providers, including hospitals and clinics, may also indirectly benefit from these products.
What are the outputs in the pseudouridine market in 2025?
The outputs in the pseudouridine market will include mRNA-based vaccines, gene therapies, and other therapeutic products incorporating pseudouridine for improved stability and efficacy. These products will be aimed at treating infectious diseases, genetic disorders, and cancer therapies, ultimately benefiting the healthcare industry.
Market Porter's Five Forces
What is the threat of new entrants in the pseudouridine market in 2025?
The threat of new entrants is moderate. While the market offers significant growth potential, the high cost of research, development, and manufacturing in the biotech and pharmaceutical sectors can act as a barrier to entry. Additionally, gaining regulatory approval for new mRNA-based therapies requires significant expertise and capital.
What is the bargaining power of suppliers in the pseudouridine market in 2025?
The bargaining power of suppliers is relatively high. Pseudouridine is a specialized product, and the synthesis of high-quality mRNA requires precise inputs. As a result, suppliers of raw materials and technological equipment hold substantial influence over pricing and availability, especially given the reliance on few key suppliers in the field.
What is the bargaining power of buyers in the pseudouridine market in 2025?
The bargaining power of buyers is moderate to low. Buyers, such as pharmaceutical companies and biotech firms, are often large and can exert some influence on prices. However, the complexity of mRNA therapies and the limited number of suppliers for high-quality pseudouridine mean that buyers have fewer alternatives and may be less able to negotiate prices aggressively.
What is the threat of substitute products in the pseudouridine market in 2025?
The threat of substitutes is moderate. While pseudouridine plays a critical role in stabilizing mRNA, other RNA modifications or delivery methods could potentially replace it in the future. However, given the effectiveness of pseudouridine in current mRNA technologies, any substitutes would need to demonstrate similar or superior benefits to pose a significant threat.
What is the intensity of competitive rivalry in the pseudouridine market in 2025?
The intensity of competitive rivalry is high. With increasing investment in mRNA-based therapies and vaccines, several established pharmaceutical and biotech companies are competing to develop and commercialize products that utilize pseudouridine. Moreover, the continuous advancement of RNA technologies means companies must stay innovative to maintain their competitive edge.
Market Upstream Analysis
What are the key raw materials for the pseudouridine market in 2025?
The key raw materials include nucleotides, enzymes, and specialized reagents needed for the synthesis of pseudouridine. Additionally, biotechnological tools for RNA modification and high-purity chemical compounds are essential to ensure the quality and effectiveness of the final product.
Who are the key suppliers in the pseudouridine market in 2025?
The key suppliers are companies specializing in the production of nucleotides, RNA synthesis platforms, and those providing chemical reagents for RNA modification. Biotech firms that manufacture and distribute RNA-related products and services will also be crucial suppliers, alongside manufacturers of laboratory equipment and technologies used in RNA research.
What is the role of research and development in the upstream part of the pseudouridine market?
Research and development play a critical role in the upstream part of the pseudouridine market. Ongoing R&D activities focus on improving the synthesis processes, enhancing the purity of pseudouridine, and discovering more efficient methods to incorporate it into mRNA-based therapies. This research drives innovation and can significantly lower production costs over time.
What are the production challenges in the upstream pseudouridine market in 2025?
Production challenges include the high cost of synthesizing pseudouridine, maintaining consistency and purity, and scaling up production for commercial use. Additionally, ensuring regulatory compliance for materials used in mRNA therapies and overcoming any technical limitations in large-scale manufacturing can also present significant hurdles.
How does regulation impact the upstream pseudouridine market in 2025?
Regulation has a significant impact on the upstream pseudouridine market. The need to adhere to stringent quality standards, safety guidelines, and approval processes from health authorities like the FDA and EMA means that suppliers must invest in compliance and validation processes. This can increase costs but is necessary to ensure the safety and efficacy of mRNA-based therapies using pseudouridine.
Market Midstream Analysis
What are the key activities in the midstream part of the pseudouridine market in 2025?
The key activities in the midstream part of the pseudouridine market include the synthesis and purification of pseudouridine, its incorporation into RNA sequences, and scaling up production for industrial use. Additionally, this phase involves the development of efficient delivery systems for mRNA therapies and ensuring compatibility with existing biotechnological platforms.
Who are the key players in the midstream pseudouridine market in 2025?
Key players in the midstream market include biotech companies specializing in RNA technology and mRNA production. These players handle the large-scale synthesis and modification of pseudouridine, as well as integration into gene therapies and vaccines. Companies involved in contract manufacturing and providing mRNA-based solutions will also be prominent in this phase.
What are the challenges in the midstream pseudouridine market in 2025?
The challenges in the midstream market include scaling up production while maintaining the quality and purity of pseudouridine, managing costs, and ensuring consistency in large batches. Additionally, optimizing RNA delivery mechanisms and addressing potential issues with stability or immune response in therapeutic applications are critical challenges.
What technological advancements are impacting the midstream pseudouridine market in 2025?
Technological advancements in RNA synthesis platforms, such as automated and high-throughput systems, are significantly impacting the midstream market. Innovations in RNA modification techniques, as well as improvements in mRNA stabilization and delivery technologies, are also playing a crucial role in increasing the efficiency and effectiveness of pseudouridine-based therapies.
How does the midstream pseudouridine market affect the overall value chain?
The midstream pseudouridine market is critical to bridging the gap between raw material supply and final product commercialization. Efficient synthesis and processing of pseudouridine, combined with technological innovation in RNA therapy production, ensure that the end product, whether a vaccine or gene therapy, is scalable, cost-effective, and meets regulatory requirements, thus driving the overall value chain.
Market Downstream Analysis
What are the key activities in the downstream part of the pseudouridine market in 2025?
The key activities in the downstream part include the final formulation of mRNA therapies, such as vaccines and gene therapies, incorporating pseudouridine for enhanced stability. This phase also involves clinical trials, distribution to healthcare providers, and commercialization. Additionally, regulatory approvals and post-market surveillance are critical components of downstream activities.
Who are the key players in the downstream pseudouridine market in 2025?
Key players in the downstream market include pharmaceutical companies, biotech firms, contract manufacturers, and distributors involved in the production and delivery of mRNA-based vaccines and therapies. Healthcare providers, such as hospitals and clinics, will also play a role in the distribution and administration of these therapies to patients.
What challenges exist in the downstream pseudouridine market in 2025?
Challenges in the downstream market include ensuring the widespread distribution of mRNA therapies, overcoming storage and stability issues (especially with cold-chain logistics), and managing regulatory compliance across different regions. Additionally, market acceptance and patient trust in mRNA-based treatments will also be crucial factors.
What technological advancements are influencing the downstream pseudouridine market in 2025?
Technological advancements such as improved mRNA delivery systems, better stabilization techniques, and more efficient production methods are influencing the downstream market. Innovations in storage solutions, including longer shelf-life formulations, and advancements in cold-chain logistics will help address distribution challenges.
How does the downstream pseudouridine market impact the overall healthcare ecosystem?
The downstream pseudouridine market has a significant impact on the healthcare ecosystem by enabling the delivery of effective mRNA-based therapies. It supports the treatment of infectious diseases, genetic disorders, and cancer, thus improving patient outcomes and transforming the way healthcare systems address complex diseases. This also contributes to the growth of the global biopharmaceutical market.
Chapter 1, to describe Pseudouridine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pseudouridine, with price, sales, revenue and global market share of Pseudouridine from 2018 to 2023.
Chapter 3, the Pseudouridine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pseudouridine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pseudouridine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pseudouridine.
Chapter 14 and 15, to describe Pseudouridine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pseudouridine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pseudouridine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Powder
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Pseudouridine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Vaccine
1.4.3 Scientific Research
1.5 Global Pseudouridine Market Size & Forecast
1.5.1 Global Pseudouridine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pseudouridine Sales Quantity (2018-2029)
1.5.3 Global Pseudouridine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 YAMASA CORPORATION
2.1.1 YAMASA CORPORATION Details
2.1.2 YAMASA CORPORATION Major Business
2.1.3 YAMASA CORPORATION Pseudouridine Product and Services
2.1.4 YAMASA CORPORATION Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 YAMASA CORPORATION Recent Developments/Updates
2.2 Biosynth Carbosynth
2.2.1 Biosynth Carbosynth Details
2.2.2 Biosynth Carbosynth Major Business
2.2.3 Biosynth Carbosynth Pseudouridine Product and Services
2.2.4 Biosynth Carbosynth Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biosynth Carbosynth Recent Developments/Updates
2.3 TriLink BioTechnologies
2.3.1 TriLink BioTechnologies Details
2.3.2 TriLink BioTechnologies Major Business
2.3.3 TriLink BioTechnologies Pseudouridine Product and Services
2.3.4 TriLink BioTechnologies Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TriLink BioTechnologies Recent Developments/Updates
2.4 MP Biomedicals, Inc
2.4.1 MP Biomedicals, Inc Details
2.4.2 MP Biomedicals, Inc Major Business
2.4.3 MP Biomedicals, Inc Pseudouridine Product and Services
2.4.4 MP Biomedicals, Inc Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MP Biomedicals, Inc Recent Developments/Updates
2.5 Thermo Scientific Chemicals
2.5.1 Thermo Scientific Chemicals Details
2.5.2 Thermo Scientific Chemicals Major Business
2.5.3 Thermo Scientific Chemicals Pseudouridine Product and Services
2.5.4 Thermo Scientific Chemicals Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Scientific Chemicals Recent Developments/Updates
2.6 BOC Sciences
2.6.1 BOC Sciences Details
2.6.2 BOC Sciences Major Business
2.6.3 BOC Sciences Pseudouridine Product and Services
2.6.4 BOC Sciences Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BOC Sciences Recent Developments/Updates
2.7 Toronto Research Chemical
2.7.1 Toronto Research Chemical Details
2.7.2 Toronto Research Chemical Major Business
2.7.3 Toronto Research Chemical Pseudouridine Product and Services
2.7.4 Toronto Research Chemical Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Toronto Research Chemical Recent Developments/Updates
2.8 Wuhan Glycogene
2.8.1 Wuhan Glycogene Details
2.8.2 Wuhan Glycogene Major Business
2.8.3 Wuhan Glycogene Pseudouridine Product and Services
2.8.4 Wuhan Glycogene Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Wuhan Glycogene Recent Developments/Updates
2.9 Ulcho Biochemical Ltd(FCAD Group)
2.9.1 Ulcho Biochemical Ltd(FCAD Group) Details
2.9.2 Ulcho Biochemical Ltd(FCAD Group) Major Business
2.9.3 Ulcho Biochemical Ltd(FCAD Group) Pseudouridine Product and Services
2.9.4 Ulcho Biochemical Ltd(FCAD Group) Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ulcho Biochemical Ltd(FCAD Group) Recent Developments/Updates
2.10 Wuhan Finetech
2.10.1 Wuhan Finetech Details
2.10.2 Wuhan Finetech Major Business
2.10.3 Wuhan Finetech Pseudouridine Product and Services
2.10.4 Wuhan Finetech Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Finetech Recent Developments/Updates
2.11 Shanghai Hongene Biotech
2.11.1 Shanghai Hongene Biotech Details
2.11.2 Shanghai Hongene Biotech Major Business
2.11.3 Shanghai Hongene Biotech Pseudouridine Product and Services
2.11.4 Shanghai Hongene Biotech Pseudouridine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Hongene Biotech Recent Developments/Updates
3 Competitive Environment: Pseudouridine by Manufacturer
3.1 Global Pseudouridine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pseudouridine Revenue by Manufacturer (2018-2023)
3.3 Global Pseudouridine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pseudouridine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pseudouridine Manufacturer Market Share in 2022
3.4.2 Top 6 Pseudouridine Manufacturer Market Share in 2022
3.5 Pseudouridine Market: Overall Company Footprint Analysis
3.5.1 Pseudouridine Market: Region Footprint
3.5.2 Pseudouridine Market: Company Product Type Footprint
3.5.3 Pseudouridine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pseudouridine Market Size by Region
4.1.1 Global Pseudouridine Sales Quantity by Region (2018-2029)
4.1.2 Global Pseudouridine Consumption Value by Region (2018-2029)
4.1.3 Global Pseudouridine Average Price by Region (2018-2029)
4.2 North America Pseudouridine Consumption Value (2018-2029)
4.3 Europe Pseudouridine Consumption Value (2018-2029)
4.4 Asia-Pacific Pseudouridine Consumption Value (2018-2029)
4.5 South America Pseudouridine Consumption Value (2018-2029)
4.6 Middle East and Africa Pseudouridine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pseudouridine Sales Quantity by Type (2018-2029)
5.2 Global Pseudouridine Consumption Value by Type (2018-2029)
5.3 Global Pseudouridine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pseudouridine Sales Quantity by Application (2018-2029)
6.2 Global Pseudouridine Consumption Value by Application (2018-2029)
6.3 Global Pseudouridine Average Price by Application (2018-2029)
7 North America
7.1 North America Pseudouridine Sales Quantity by Type (2018-2029)
7.2 North America Pseudouridine Sales Quantity by Application (2018-2029)
7.3 North America Pseudouridine Market Size by Country
7.3.1 North America Pseudouridine Sales Quantity by Country (2018-2029)
7.3.2 North America Pseudouridine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pseudouridine Sales Quantity by Type (2018-2029)
8.2 Europe Pseudouridine Sales Quantity by Application (2018-2029)
8.3 Europe Pseudouridine Market Size by Country
8.3.1 Europe Pseudouridine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pseudouridine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pseudouridine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pseudouridine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pseudouridine Market Size by Region
9.3.1 Asia-Pacific Pseudouridine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pseudouridine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pseudouridine Sales Quantity by Type (2018-2029)
10.2 South America Pseudouridine Sales Quantity by Application (2018-2029)
10.3 South America Pseudouridine Market Size by Country
10.3.1 South America Pseudouridine Sales Quantity by Country (2018-2029)
10.3.2 South America Pseudouridine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pseudouridine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pseudouridine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pseudouridine Market Size by Country
11.3.1 Middle East & Africa Pseudouridine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pseudouridine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pseudouridine Market Drivers
12.2 Pseudouridine Market Restraints
12.3 Pseudouridine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pseudouridine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pseudouridine
13.3 Pseudouridine Production Process
13.4 Pseudouridine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pseudouridine Typical Distributors
14.3 Pseudouridine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pseudouridine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pseudouridine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. YAMASA CORPORATION Basic Information, Manufacturing Base and Competitors
Table 4. YAMASA CORPORATION Major Business
Table 5. YAMASA CORPORATION Pseudouridine Product and Services
Table 6. YAMASA CORPORATION Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. YAMASA CORPORATION Recent Developments/Updates
Table 8. Biosynth Carbosynth Basic Information, Manufacturing Base and Competitors
Table 9. Biosynth Carbosynth Major Business
Table 10. Biosynth Carbosynth Pseudouridine Product and Services
Table 11. Biosynth Carbosynth Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Biosynth Carbosynth Recent Developments/Updates
Table 13. TriLink BioTechnologies Basic Information, Manufacturing Base and Competitors
Table 14. TriLink BioTechnologies Major Business
Table 15. TriLink BioTechnologies Pseudouridine Product and Services
Table 16. TriLink BioTechnologies Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TriLink BioTechnologies Recent Developments/Updates
Table 18. MP Biomedicals, Inc Basic Information, Manufacturing Base and Competitors
Table 19. MP Biomedicals, Inc Major Business
Table 20. MP Biomedicals, Inc Pseudouridine Product and Services
Table 21. MP Biomedicals, Inc Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MP Biomedicals, Inc Recent Developments/Updates
Table 23. Thermo Scientific Chemicals Basic Information, Manufacturing Base and Competitors
Table 24. Thermo Scientific Chemicals Major Business
Table 25. Thermo Scientific Chemicals Pseudouridine Product and Services
Table 26. Thermo Scientific Chemicals Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Thermo Scientific Chemicals Recent Developments/Updates
Table 28. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 29. BOC Sciences Major Business
Table 30. BOC Sciences Pseudouridine Product and Services
Table 31. BOC Sciences Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. BOC Sciences Recent Developments/Updates
Table 33. Toronto Research Chemical Basic Information, Manufacturing Base and Competitors
Table 34. Toronto Research Chemical Major Business
Table 35. Toronto Research Chemical Pseudouridine Product and Services
Table 36. Toronto Research Chemical Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Toronto Research Chemical Recent Developments/Updates
Table 38. Wuhan Glycogene Basic Information, Manufacturing Base and Competitors
Table 39. Wuhan Glycogene Major Business
Table 40. Wuhan Glycogene Pseudouridine Product and Services
Table 41. Wuhan Glycogene Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Wuhan Glycogene Recent Developments/Updates
Table 43. Ulcho Biochemical Ltd(FCAD Group) Basic Information, Manufacturing Base and Competitors
Table 44. Ulcho Biochemical Ltd(FCAD Group) Major Business
Table 45. Ulcho Biochemical Ltd(FCAD Group) Pseudouridine Product and Services
Table 46. Ulcho Biochemical Ltd(FCAD Group) Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ulcho Biochemical Ltd(FCAD Group) Recent Developments/Updates
Table 48. Wuhan Finetech Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Finetech Major Business
Table 50. Wuhan Finetech Pseudouridine Product and Services
Table 51. Wuhan Finetech Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Finetech Recent Developments/Updates
Table 53. Shanghai Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Hongene Biotech Major Business
Table 55. Shanghai Hongene Biotech Pseudouridine Product and Services
Table 56. Shanghai Hongene Biotech Pseudouridine Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Hongene Biotech Recent Developments/Updates
Table 58. Global Pseudouridine Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 59. Global Pseudouridine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Pseudouridine Average Price by Manufacturer (2018-2023) & (US$/g)
Table 61. Market Position of Manufacturers in Pseudouridine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Pseudouridine Production Site of Key Manufacturer
Table 63. Pseudouridine Market: Company Product Type Footprint
Table 64. Pseudouridine Market: Company Product Application Footprint
Table 65. Pseudouridine New Market Entrants and Barriers to Market Entry
Table 66. Pseudouridine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Pseudouridine Sales Quantity by Region (2018-2023) & (Kg)
Table 68. Global Pseudouridine Sales Quantity by Region (2024-2029) & (Kg)
Table 69. Global Pseudouridine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Pseudouridine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Pseudouridine Average Price by Region (2018-2023) & (US$/g)
Table 72. Global Pseudouridine Average Price by Region (2024-2029) & (US$/g)
Table 73. Global Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 74. Global Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 75. Global Pseudouridine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Pseudouridine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Pseudouridine Average Price by Type (2018-2023) & (US$/g)
Table 78. Global Pseudouridine Average Price by Type (2024-2029) & (US$/g)
Table 79. Global Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 80. Global Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 81. Global Pseudouridine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Pseudouridine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Pseudouridine Average Price by Application (2018-2023) & (US$/g)
Table 84. Global Pseudouridine Average Price by Application (2024-2029) & (US$/g)
Table 85. North America Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 86. North America Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 87. North America Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 88. North America Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 89. North America Pseudouridine Sales Quantity by Country (2018-2023) & (Kg)
Table 90. North America Pseudouridine Sales Quantity by Country (2024-2029) & (Kg)
Table 91. North America Pseudouridine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Pseudouridine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 94. Europe Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 95. Europe Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 96. Europe Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 97. Europe Pseudouridine Sales Quantity by Country (2018-2023) & (Kg)
Table 98. Europe Pseudouridine Sales Quantity by Country (2024-2029) & (Kg)
Table 99. Europe Pseudouridine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Pseudouridine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 102. Asia-Pacific Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 103. Asia-Pacific Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 104. Asia-Pacific Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 105. Asia-Pacific Pseudouridine Sales Quantity by Region (2018-2023) & (Kg)
Table 106. Asia-Pacific Pseudouridine Sales Quantity by Region (2024-2029) & (Kg)
Table 107. Asia-Pacific Pseudouridine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Pseudouridine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 110. South America Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 111. South America Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 112. South America Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 113. South America Pseudouridine Sales Quantity by Country (2018-2023) & (Kg)
Table 114. South America Pseudouridine Sales Quantity by Country (2024-2029) & (Kg)
Table 115. South America Pseudouridine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Pseudouridine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Pseudouridine Sales Quantity by Type (2018-2023) & (Kg)
Table 118. Middle East & Africa Pseudouridine Sales Quantity by Type (2024-2029) & (Kg)
Table 119. Middle East & Africa Pseudouridine Sales Quantity by Application (2018-2023) & (Kg)
Table 120. Middle East & Africa Pseudouridine Sales Quantity by Application (2024-2029) & (Kg)
Table 121. Middle East & Africa Pseudouridine Sales Quantity by Region (2018-2023) & (Kg)
Table 122. Middle East & Africa Pseudouridine Sales Quantity by Region (2024-2029) & (Kg)
Table 123. Middle East & Africa Pseudouridine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Pseudouridine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Pseudouridine Raw Material
Table 126. Key Manufacturers of Pseudouridine Raw Materials
Table 127. Pseudouridine Typical Distributors
Table 128. Pseudouridine Typical Customers
List of Figures
Figure 1. Pseudouridine Picture
Figure 2. Global Pseudouridine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pseudouridine Consumption Value Market Share by Type in 2022
Figure 4. Powder Examples
Figure 5. Liquid Examples
Figure 6. Global Pseudouridine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pseudouridine Consumption Value Market Share by Application in 2022
Figure 8. Vaccine Examples
Figure 9. Scientific Research Examples
Figure 10. Global Pseudouridine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pseudouridine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pseudouridine Sales Quantity (2018-2029) & (Kg)
Figure 13. Global Pseudouridine Average Price (2018-2029) & (US$/g)
Figure 14. Global Pseudouridine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pseudouridine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pseudouridine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pseudouridine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pseudouridine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pseudouridine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pseudouridine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pseudouridine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pseudouridine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pseudouridine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pseudouridine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pseudouridine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pseudouridine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pseudouridine Average Price by Type (2018-2029) & (US$/g)
Figure 29. Global Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pseudouridine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pseudouridine Average Price by Application (2018-2029) & (US$/g)
Figure 32. North America Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pseudouridine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pseudouridine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pseudouridine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pseudouridine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pseudouridine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pseudouridine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pseudouridine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pseudouridine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pseudouridine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pseudouridine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pseudouridine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pseudouridine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pseudouridine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pseudouridine Market Drivers
Figure 73. Pseudouridine Market Restraints
Figure 74. Pseudouridine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pseudouridine in 2022
Figure 77. Manufacturing Process Analysis of Pseudouridine
Figure 78. Pseudouridine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
